Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
Frontiers in Medicine ; 9:1033181, 2022.
Article in English | MEDLINE | ID: covidwho-2215332

ABSTRACT

Background: Complementary and Integrative Medicine (CIM), including self-care healthy life-style promotion strategies, is widely used in Germany. Aim of this study was to assess the use of self-care and lifestyle interventions as well as mental/emotional state experienced during the COVID-19 pandemic.

2.
Cattle Practice ; 29(1):12-12, 2021.
Article in English | CAB Abstracts | ID: covidwho-2033861

ABSTRACT

The aims of this study are to determine if CAM use has potential to reduce unnecessary antibiotic use and support the global efforts against antimicrobial resistance, and to ensure that antimicrobials and other conventional treatment approaches are used where appropriate. 20 farms with a range of management systems, herd sizes and production goals were recruited to this study. Interviews were conducted with 24 farmers through a mixture of face-to-face, telephone and videoconferencing modalities necessitated by movement restrictions during the Covid-19 pandemic. In addition, 16 farms were visited to collect ethnographic participant observational data using ethnographic fieldnotes and photographs. Interviews were conducted using a topic guide and explored participants' experience of CAM, including drivers/barriers to CAM use, experiences of CAM use and how CAM might influence the use of conventional medicine such as antibiotics. Early findings indicate several drivers for UK dairy farmers to use CAM approaches, including their own personal [or friends' and relations'] experiences, the views of influential people and advisors, networks within the farming community and the fact that CAM use allows a greater sense of autonomy in health-based decision making. Farmers often refer to milk buyers and organic guidelines as factors which influence their use of CAM. They further refer to a desire to 'do something' for the animal and to minimise animal welfare related concerns. A range of CAM information sources were also consulted by farmers including, holistic health management organisations/courses, online materials, and pharmacies. Participating farmers associate the use of CAM approaches with other holistic health management practices, human-animal interactions, the actual character and physical characteristics of an animal and animal welfare. This indicates that CAM use is seen by farmers as part of a wider ethos and belief about holistic farming practices and land use. Additionally, data implies that some farmers value their positive personal experiences of CAM use over scientific evidence. In contrast, barriers to CAM use were also identified including: the perception that CAM approaches are reserved specifically for organic systems, little access to CAM and related resources and some existing tensions between farmers and other stakeholders' views. Early findings suggest that farmers are influenced in their use of CAM by a range of individuals within the agriculture community, including veterinary surgeons (some of whom use homeopathic practices), mainstream farming press and pro-CAM organisations and advisors.

3.
Eur Rev Med Pharmacol Sci ; 26(3): 1033-1041, 2022 02.
Article in English | MEDLINE | ID: covidwho-1700492

ABSTRACT

OBJECTIVE: Coronavirus disease 2019 (COVID-19) is a debilitating disease with numerous medical and non-medical consequences. Our study aimed to evaluate the efficacy of Persian barley water in controlling the clinical outcomes of hospitalized COVID-19 patients. PATIENTS AND METHODS: This was a single-blind, add-on therapy, randomized controlled clinical trial conducted in Shiraz, Iran, from January to March 2021. One hundred hospitalized COVID-19 patients with moderate disease severity were randomly allocated to receive routine treatment (per local protocols) with or without 250 ml of Persian barley water (PBW) daily for two weeks. Clinical outcomes and blood tests were recorded before and after the study period. Multivariable modeling was applied using Stata software for data analysis. RESULTS: The PBW product passed our standardization and safety assessments. Length of hospital stay (LHS) was 4.5 days shorter in the intervention group than the control group regardless of history of cigarette smoking (95% confidence interval: -7.22, -1.79 days). Also, body temperature, erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), and creatinine significantly dropped in the intervention group compared to the control group. No adverse events related to PBW occurred. CONCLUSIONS: This clinical trial demonstrated the efficacy of PBW in minimizing the LHS, fever, and levels of ESR, CRP, and creatinine among hospitalized COVID-19 patients with moderate disease severity. More robust trials can help find safe and effective herbal formulations as treatments for COVID-19.


Subject(s)
COVID-19/therapy , Hordeum , /methods , Adult , Aged , Blood Sedimentation/drug effects , C-Reactive Protein/drug effects , Creatinine , Fever/therapy , Hospitalization , Humans , Length of Stay , Male , Middle Aged , Severity of Illness Index , Single-Blind Method , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL